Eli Lilly
International pharmaceutical websites under FDA regulatory constraints
The Company
Eli Lilly is one of the world's largest pharmaceutical companies, with medicines reaching patients across 95+ countries and a market cap exceeding $700B. Beyond drug development, Lilly has made a serious push into consumer digital health through LillyDirect, the Lilly Health app for Zepbound and Mounjaro patients, and expanded telehealth services across chronic disease management. As a principal designer embedded in a small internal team operating as an agency within the larger organization, I owned end-to-end design of international medication websites serving both consumer and clinician audiences, while contributing to the internal design system and navigating the constraints of FDA regulatory and medical-legal review processes throughout.
The Work
Principal designer embedded in a small eight-person internal design team operating as an agency within one of the world's largest pharmaceutical companies. I owned end-to-end design of international medication websites serving two distinct audiences simultaneously: consumer-facing patient sites and separate clinician-facing HCP sites across responsive web.
Contributed to the internal design system and operated within strict FDA regulatory and HIPAA compliance requirements throughout every project lifecycle, navigating pharmaceutical marketing guidelines and medical-legal review processes on every deliverable.
Key Contributions
- Owned end-to-end design of international medication websites serving consumer and clinician audiences simultaneously
- Contributed to internal design system supporting consistent, scalable design across Lilly's digital product portfolio
- Operated within strict FDA regulatory and HIPAA compliance requirements across every project lifecycle